BlackRock Fund Advisors - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 89 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$36,211,000
+36.8%
2,270,297
+42.7%
0.01%
+40.0%
Q3 2016$26,476,000
+56.0%
1,591,102
+4.9%
0.01%
+25.0%
Q2 2016$16,975,000
+23.7%
1,517,007
-7.6%
0.00%
+33.3%
Q1 2016$13,728,000
-9.1%
1,642,070
+1.2%
0.00%0.0%
Q4 2015$15,109,000
-20.5%
1,622,846
-3.7%
0.00%
-40.0%
Q3 2015$19,004,000
-8.8%
1,684,784
+2.6%
0.01%0.0%
Q2 2015$20,833,000
+50.8%
1,641,711
+10.5%
0.01%
+66.7%
Q1 2015$13,812,000
-37.9%
1,485,191
-4.4%
0.00%
-40.0%
Q4 2014$22,243,000
+74.3%
1,553,289
+26.3%
0.01%
+25.0%
Q3 2014$12,763,000
-36.6%
1,229,530
-1.2%
0.00%
-33.3%
Q2 2014$20,133,000
-7.3%
1,244,343
-6.9%
0.01%0.0%
Q1 2014$21,711,000
+36.8%
1,336,039
+4.5%
0.01%
+20.0%
Q4 2013$15,873,000
+11.5%
1,279,081
-1.6%
0.01%0.0%
Q3 2013$14,236,000
+81.9%
1,300,131
+34.2%
0.01%
+66.7%
Q2 2013$7,825,000968,5010.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders